Recent studies provided mechanistic insight, proposing disease-associated Anxa11 mutations to contribute to ALS pathogenesis through dysregulated Ca2+ homeostasis and abnormal protein aggregation [433]. This evidence concerns the gene ANXA11 and amyotrophic lateral sclerosis.